- Home
- ATOM vs ZNTL Comparison
ATOM vs ZNTL Comparison
Compare ATOM & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOM
- ZNTL
- Stock Information
- Founded
- ATOM 2001
- ZNTL 2014
- Country
- ATOM United States
- ZNTL United States
- Employees
- ATOM N/A
- ZNTL N/A
- Industry
- ATOM Semiconductors
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- ATOM Technology
- ZNTL Health Care
- Exchange
- ATOM Nasdaq
- ZNTL Nasdaq
- Market Cap
- ATOM 121.0M
- ZNTL 102.2M
- IPO Year
- ATOM 2016
- ZNTL 2020
- Fundamental
- Price
- ATOM $6.44
- ZNTL $1.23
- Analyst Decision
- ATOM Strong Buy
- ZNTL Buy
- Analyst Count
- ATOM 1
- ZNTL 8
- Target Price
- ATOM $7.00
- ZNTL $8.53
- AVG Volume (30 Days)
- ATOM 395.4K
- ZNTL 752.0K
- Earning Date
- ATOM 05-06-2025
- ZNTL 05-20-2025
- Dividend Yield
- ATOM N/A
- ZNTL N/A
- EPS Growth
- ATOM N/A
- ZNTL N/A
- EPS
- ATOM N/A
- ZNTL N/A
- Revenue
- ATOM $121,000.00
- ZNTL $67,425,000.00
- Revenue This Year
- ATOM $580.00
- ZNTL N/A
- Revenue Next Year
- ATOM N/A
- ZNTL N/A
- P/E Ratio
- ATOM N/A
- ZNTL N/A
- Revenue Growth
- ATOM N/A
- ZNTL N/A
- 52 Week Low
- ATOM $2.31
- ZNTL $1.01
- 52 Week High
- ATOM $17.55
- ZNTL $13.24
- Technical
- Relative Strength Index (RSI)
- ATOM 71.38
- ZNTL 38.08
- Support Level
- ATOM $4.58
- ZNTL $1.33
- Resistance Level
- ATOM $6.96
- ZNTL $1.32
- Average True Range (ATR)
- ATOM 0.50
- ZNTL 0.10
- MACD
- ATOM 0.32
- ZNTL -0.00
- Stochastic Oscillator
- ATOM 83.54
- ZNTL 8.22
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.